1. DNA Patenting
These include the rights to the primary breast and ovarian cancer genes (Mick, 2010). ... While they also have done extensive research into colon, uterine, prostate, and pancreatic cancers, as well as melanomas, their current main focus according to their website is breast and ovarian cancers. ... Despite the ruling, the U.S. government has issued two patents for breast cancer genes, BRCA 1 and BRCA 2, in 1997 and 2000 respectively. ... Myriad uses their patents to block breast cancer research at a university level. Because Myriad charges far too much to allow access to the genes for study, th...
- Word Count: 1285
- Approx Pages: 5
- Grade Level: High School